IPI-926 News
Most Popular IPI-926 Story
Infinity gets $75M for cancer partnership
Infinity Pharmaceuticals is getting $75 million up-front in a partnership deal for the company's early-stage research. Purdue Pharma and affiliate Mundipharma are buying 4 million shares of Infinity Read more...
Latest Headlines
- November 21, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
